Board Of Directors
Our highly experienced Board of Directors
They provide cross-functional governance, strategic business solutions and innovative insights that drive our business. Our Board comprises a healthy mix of entrepreneurs and professionals, both in executive and non-executive roles.
Chairman and Managing Director
Mr. Krishna Prasad Chigurupati is the Founder of Granules and has more than three decades of experience in the pharmaceutical industry. In 1984, he set up a paracetamol manufacturing facility, which has become one of the world’s reputed manufacturers of paracetamol in the regulated markets. Mr. Prasad pioneered and popularised the concept of Pharmaceutical Formulations Intermediates (PFIs) as a cost-efficient product for global formulations manufacturers.
Mr. L. S. Sarma, is a retired Bank Executive. Mr. Sarma was a General Manager at the Industrial Development Bank of India (IDBI), as well as the Director of ECGC and Dena Bank. He worked for International Trade Centre, Geneva, (UNCTAD/GATT) as an Export Credit Consultant and also coauthored a publication of ITC on Export Credit in developing countries. He was an adviser to the Development Bank of Mauritius for over 5 years and also represented that Country as well as Botswana for industrial promotion from India.
Mr. Kurian has a rich career in the financial services area of nearly five decades. Starting as Research Officer in Reserve Bank of India, he grew up to the rank of Advisor - Economics Department. During 1975-1993, Mr. Kurian was with Unit Trust of India and held several positions including Director-Investments, Director-Planning and Development and as Executive Trustee.
After retiring from Unit Trust of India, he joined the Apple Mutual Fund as Advisor from 1993 to 1998. From 1998 to 2010 he was the Executive Chairman of Association of Mutual Funds in India. He was a Consultant to the Commonwealth Secretariat and was on the Board of National Stock Exchange, Executive Committee of National Depositories, SEBI Mutual Fund Advisory Committee and on several Mutual Fund Industry Committees. He has extensive exposure in the international mutual fund industry. He was a Commonwealth Consultant and was the founder Director of Ceybank Unit Trust of SriLanka.
Mr. C. Parthasarathy is one of the founders of Karvy Group. As the Chairman of the group, he has been responsible for building Karvy as one of India’s truly integrated financial services organizations. He oversees the group’s operations and is responsible for the vision, business direction and technology value addition to the overall business. Mr. Parthasarathy is a fellow member of the Institute of Chartered Accountants of India and the Institute of Company Secretaries of India. He also holds graduate degrees in Science and Law. Mr. Parthasarathy has been actively associated with various professional bodies in senior capacities over the last decade. Under his stewardship, Karvy has grown into an all India organization enjoying leadership positions in most business segments in which it is present.
Dr. Krishna M. Ella, the Chairman and Managing Director of Bharat Biotech International Ltd. (Bharat Biotech) completed Ph.D. from University of Wisconsin-Madison. He advised the former Chief Minister of A.P to set up a Biotech Park which lead to Genome Valley, Hyderabad. Hon’ble Prime Minister, Shri. Narendra Modi has launched ROTAVAC®, the first novel vaccine which is completely developed in India, completed efficacy trials.
Dr. Ella has been awarded more than 100 National and International awards which include Bio Spectrum Person of the Year in 2013, University of Wisconsin Distinguished Alumni Award (2011), Business Leader of the Year 2011, Best Technology and Innovation Award from the Prime Minister of India in 2008 are few among them. He served in different committees prominent among them are (1) Member of the Scientific Advisory Committee to the Cabinet (SAC-C); (2) Member of the Governing Body of the Council of Scientific & Industrial Research (CSIR); (3) Member of the Governing Council of Technology Information, Forecasting and Assessment Council (TIFAC); (4) Former Chairperson of the Board of Governors of the National Institute of Technology, Warangal (NIT W); (5) Co-Chairman of Indo-USA High Technology Cooperation Group (HTCG) for 5 years on behalf of Govt. of India and facilitated knowledge initiative bill signed by USA.
Mr. Akinepally Arun Rao did his B.Tech in Chemical Engineering from the University of Madras and an MS from the Illinois Institute of Technology, Chicago, USA. He is the Executive Director of Akin Laboratories Pvt. Ltd., a formulation manufacturing Company. Mr. Arun Rao is on the Board of ESPI Industries and Chemicals Pvt. Ltd, a leading manufacturer of antacids in India and SANZYME PVT LTD a globally known manufacturer of Probiotics. Mr. Arun Rao is an office bearer of the Indian Pharmaceutical Council Association at the State level and was also a member of the Central Executive Council at the National level. He is also a member of Executive Committee of the Organization of Pharmaceutical Manufacturers, Hyderabad
Non-Executive, Non-Independent Director
Mr. Harsha Chigurupati has been with Granules since 2005 and served as CMO from 2006-2010 and as an Executive Director from 2010-2015. As CMO, Mr. Chigurupati was instrumental in commercializing the Company’s Finished Dosage Division and also changed the Company’s focus to marquee customers in the regulated markets. As an Executive Director, Mr. Chigurupati was responsible for the standalone operation of Granules India including the P&L. Mr. Chigurupati has a Bachelor of Science in Business Management from Boston University.
Mrs. Uma Devi Chigurupati has rich experience of 30 years in various fields. Mrs. Uma with Mr. Krishna Prasad Chigurupati had co-founded Triton Laboratories Private Limited in the year 1984, which was later amalgamated with Granules India Limited. Presently, she is spear heading CSR activities and HR initiatives.
Non-Executive ,Non-Independent Director
Mr. K. B. Sankar Rao is a post graduate from Andhra University and has rich experience of about 34 years in various domains. Mr. K. B. Sankar Rao was associated with various reputed organizations like Warner Hindustan, Cipla Limited and Dr. Reddy’s Laboratories Limited. He has varied experience in the fields of technical operations, quality, supply chain, development & launch of APIs and finished dosages for global markets and business strategy. Mr. K.B. Sankar Rao is also Managing Director of Raje Retail Pvt Ltd, a pharmacy retail chain under the brand name- “My Health Pharmacy” in Hyderabad.
Dr. Prasada Raju has over two decades of techno commercial experience in global pharmaceutical space. Previously, he was associated with Dr. Reddy’s; where his work centered around developing new products, fostering strategic partnerships, driving synergies between industry and academia, expanding to new geographies and handling IP driven early product portfolio development and program management.